| ￥3500 | |
| Z03853-100 | |
|
|
|
|
|
|
|
|
|
| Species | Cynomolgus/Rhesus macaque | ||||
| Protein Construction |
|
||||
| Purity |
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Immobilized BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque (Cat.No.: Z03853) at 1 μg/ml (100μl/Well) on the platecan bind Biotinylated Anti-BCMA Antibody. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 31.5 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 35-45 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4. | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Immobilized BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque, hFc Tag at 1 μg/ml (100 μL/well) on the plate. Dose response curve for Biotinylated Anti-BCMA Antibody, hFc Tag with the EC50 of 9.1 ng/ml determined by ELISA. »
The purity of BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque is greater than 95% as determined by SEC-HPLC. »
BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | BCMA (B-cell maturation antigen), also called TNFRSF17, is encoded by the TNFRSF17 gene. It acts as a cell surface receptor of the TNF receptor superfamily. BCMA recognizes B-cell activating factor (BAFF). It interacts with the B-cell activating factor TNFSF13B. |
| Synonyms | CD269; TNFRSF17; BCMA; BCM; TNFRSF13A |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
